Multimeric Biotherapeutics, Inc.

MegaLigand image

Clinical Pipeline
Product Pipeline
Multimeric is a clinical stage company based on multimeric forms of TNFSF ligands. One molecule in this series, MegaFasL™ (APO010), has already been placed into a clinical trial by Topotarget A/S. With the exeption of this one molecule (in which Topotarget retains certain rights), Multimeric has exclusive licenses to all of the MegaLigands™ and UltraLigands™.